THE ACNE BRIEF · TREATMENTS, EXPLAINEDRESEARCHED OCTOBER 2026
acne brief05
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
Leave-on salicylic-acid liquid

Obagi CLENZIderm Pore Therapy review

A 2% salicylic-acid leave-on liquid with alcohol, menthol and fragrance in the declaration. Manufacturer consumer data should stay separate from a controlled acne-treatment comparison.

Obagi Pore Therapy broadens this cream directory with a clearly identified liquid format. The public listing names a 2% salicylic-acid concentration, which answers one useful label question. It does not settle how the supporting formulation will feel or how the product compares clinically with another treatment.

We examined the official product and direct refund pages on October 14, 2026, with AAD new-product guidance as context. The Acne Brief did not apply the liquid, purchase it or observe acne outcomes. The review follows the precise product record and distinguishes consumer impressions from stronger comparative claims.

Obagi CLENZIderm Pore Therapy: 2% salicylic acid liquid, Read the complete vehicle, Consumer data dated 2024
Editorial diagram of the documented facts. No product-use test or patient result is depicted.
Format
Leave-on liquid
Active
2% salicylic acid
Displayed price
$50
Supporting ingredients
SD Alcohol 40-B, fragrance and menthol
Evidence date
2024 manufacturer consumer data on file

The named active belongs to a leave-on liquid

Pore Therapy is listed as a 2% salicylic-acid product in a liquid format. It should remain distinct from a cream, rinse-off cleanser or prescription blend when comparing the step it would occupy in a routine. The concentration is not a universal measure of the complete preparation’s performance. [1]

The ingredient brief explains why an active’s job and the surrounding formulation belong in the same comparison. We do not infer a dosage-equivalence rule between Pore Therapy and every other product carrying a 2% label, or provide an application schedule from that number alone.

The supporting declaration deserves a full reading

The published ingredients include SD Alcohol 40-B, fragrance and menthol. Those materials are relevant details for a reader examining prior sensitivities or the overall vehicle. Their presence is not, by itself, a measured prediction of harm or a guarantee that the liquid will feel uncomfortable. [1]

We have not assessed sting, cooling, dryness or residue firsthand. Nor should a cooling sensation be treated as evidence that acne is responding. Keep subjective feel, ingredient identity and clinical outcomes separate when discussing the product with a professional or comparing it with an existing routine.

The dated consumer evidence is from 2024

The manufacturer attributes consumer-result material to 2024 data on file. This review retains that date rather than labeling the evidence as a newly completed 2026 study. The account describes manufacturer-held information, not a complete independent report appraised by this publication. [1]

Consumer impressions can be useful, but they do not automatically establish blinded clinical lesion counts, superiority to another active or the same response for every purchaser. The study population, endpoint and comparison conditions would be needed to draw those stronger conclusions. A recent webpage check does not change the underlying evidence date.

Pore Therapy is only one part of a wider catalog

The CLENZIderm name can appear alongside other products, and Obagi also sells pigment preparations and retinoid products. Their ingredients and trial claims should not be transferred into this liquid’s review. A shared brand does not turn separate purchases into one tested formula or one necessary regimen.

The Arencia comparison illustrates a rinse-off format with different disclosure limits. Our routine guide asks what is already in use before considering another step. This publication gives no instruction to combine multiple exfoliating or prescription products.

The current product offer is fifty dollars

The captured direct listing displayed $50 for Pore Therapy. That is a product-page observation, not a completed transaction including shipping and tax. We did not verify local stock, any professional-office price or an address-specific delivery estimate. Other Obagi products have separate prices. [1]

The purchase-cost guide helps keep a single liquid apart from the cost of a complete regimen. Do not invent a monthly expense from an unverified number of uses. A shipping threshold or promotional condition also needs to be matched to the actual selected order.

The direct refund conditions need an eligible order

Obagi’s direct policy describes a thirty-day period from delivery, with exclusions and conditions that need checking for the item purchased. Samples are final sale, and shipping charges are not included in the refund promise. A different retailer may apply a different agreement. [2]

The existence of a policy does not show that this publication successfully returned a bottle or received a timely payment. Keep the order confirmation and applicable terms, and establish authorization requirements directly. A short satisfaction statement should not be expanded into a universal no-cost return for every purchase.

A defined label is useful without a superiority claim

Pore Therapy provides a specific active percentage and a supporting ingredient declaration, which make the product easier to identify than an incompletely labeled bundle. The checked consumer evidence and our lack of hands-on testing limit what can be said about individual comfort or comparative results.

AAD’s new-product guidance provides general context rather than approval of this formula. Medical questions and persistent acne deserve an appropriate assessment. CoreAge Rx’s advertising is separately disclosed and supplies no evidence of clinical superiority over Obagi. The brief’s conclusion is a clearer product record, not a prescribed routine or a numeric score. [3]

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.

  1. Acne Toner & Pore-Reducing Therapy | Obagi Pore TherapyOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
  2. Refund policy – ObagiOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
  3. How to test skin care productsIndependent clinical or regulatory context · Checked October 14, 2026

Keep reading